Atlas Trials

SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis

Clinical trial NCT07384234 · RECRUITING

Trial details

NCT number
NCT07384234
Sponsor
Ruijin Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Start date
2026-04-24
Primary completion
2028-12-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.